UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
COMMISSION FILE NUMBER 001-38455
MorphoSys AG
Semmelweisstrasse 7
82152 Planegg
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨
On April 18, 2024, MorphoSys AG (the “Company”) published three notifications of major holdings from DWS Investment GmbH, BNP Paribas and Novartis AG.
Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
MORPHOSYS AG (Registrant)
Date: April 18, 2024
By: /s/ i.A. Inge Altinger-Ralle
Name: Inge Altinger-Ralle
Title: Specialist Corporate Publishing
By: /s/ i.A. Robert Mayer
Name: Robert Mayer
Title: Director Investor Relations